SOD can help manage cellular damage due to aging or illness.
Moreover, our study provides a guide for design of future PPAR agonists that should be screened for lack of inhibition of PGC1 activity
Your feedback helps us improve and helps others make informed decisions
Phys Ther Sport 14(2):124130 Zayni R, Thaunat M, Fayard JM et al (2015) Platelet-rich plasma as a treatment for chronic patellar tendinopathy: comparison of a single versus two consecutive injections
In the U.S, the incidence is approximately 1: 142,000 based on newborn screening data.[10] In Japan, the incidence is approximately 1 in 40,000.[11] The Faroe Islands, an archipelago in the North Atlantic, report the highest incidence of PCD, which is 1 in 300.[12] Some patients with PCD have no or minimal symptoms, and this milder phenotype may remain undiagnosed throughout their entire life